1. PO-111 Blood group B is a potent risk factor for venous thromboembolism in glioblastoma multiforme. Issue 200 (April 2021) Authors: Heenkenda, K.M.; Malmström, A.; Lysiak, M.; Mudaisi, M.; Bratthäll, C.; Milos, P.; Strandeus, M.; Åkesson, L.; Söderkvist, P.; Uppugunduri, S.; Osman, A.M. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prognostic value of O‐6‐methylguanine–DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis. (28th June 2017) Authors: Dahlrot, R. H.; Dowsett, J.; Fosmark, S.; Malmström, A.; Henriksson, R.; Boldt, H.; de Stricker, K.; Sørensen, M. D.; Poulsen, H. S.; Lysiak, M.; Söderkvist, P.; Rosell, J.; Hansen, S.; Kristensen, B. W. Journal: Neuropathology & applied neurobiology Issue: Volume 44:Number 2(2018) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗